37.39 0.00 (0.00%)
After hours: 4:51PM EDT
|Bid||37.41 x 1800|
|Ask||37.42 x 800|
|Day's Range||36.90 - 37.52|
|52 Week Range||25.82 - 37.52|
|Beta (3Y Monthly)||0.13|
|PE Ratio (TTM)||18.29|
|Earnings Date||Oct 30, 2019|
|Forward Dividend & Yield||1.48 (4.02%)|
|1y Target Est||35.99|
There are several ways to beat the market, and investing in small cap stocks has historically been one of them. We like to improve the odds of beating the market further by examining what famous hedge fund operators such as Jeff Ubben, George Soros and Carl Icahn think. Those hedge fund operators make billions of […]
It’s been a good year for real estate investments, but one Wall Street analyst said Tuesday that there’s even more upside ahead. The Analyst JPMorgan analyst Michael Mueller made the following adjustments ...
IRVINE, Calif. , Oct. 3, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) is scheduled to report its third quarter 2019 financial results after the close of trading on the New York Stock Exchange on Wednesday, ...
HCP's mutually-beneficial agreement with Brookdale reduces the operator's concentration in the company's portfolio to 8% and enables transitions to Life Care Services under a highly-incentivized contract.
IRVINE, Calif. , Oct. 1, 2019 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) today announced that Fitch Ratings ("Fitch") upgraded HCP's corporate credit rating to BBB+ from BBB, with a stable outlook. ...
IRVINE, Calif., Oct. 1, 2019 /PRNewswire/ -- HCP, Inc. (HCP) today announced several transactions with Brookdale Senior Living Inc. ("Brookdale") related to HCP's 15-campus CCRC JV and triple-net portfolio with Brookdale that will position HCP to: (i) improve operator diversification, (ii) acquire Brookdale's interest in 12 CCRC campuses and (iii) strengthen the remaining Brookdale triple-net portfolio.
Moody's Investors Service ("Moody's") has assigned a Prime-2 (P-2) short-term rating to HCP, Inc's $1 billion senior unsecured commercial paper (CP) program in the U.S. Concurrently, Moody's also affirmed all existing ratings of HCP, including its Baa1 senior unsecured debt rating. HCP's P-2 short-term rating reflects the healthcare REIT's strong liquidity position supported by its large unsecured revolving credit facility with a total capacity of $2.5 billion. The CP notes will be issued by HCP, Inc. and rank pari-passu with the REIT's other unsecured senior debt.
IRVINE, Calif., Sept. 18, 2019 /PRNewswire/ -- HCP, Inc. (HCP) announced today that it has established an unsecured commercial paper program (the "Commercial Paper Program"). Under the terms of the Commercial Paper Program, HCP may issue, from time to time, unsecured short-term debt securities with varying maturities not in excess of 397 days from the date of issue (the "Notes"). Amounts available under the Commercial Paper Program may be borrowed, repaid and re-borrowed from time to time, with the maximum aggregate face or principal amount of Notes outstanding at any one time not exceeding $1.0 billion. The proceeds of the Notes will be used for general corporate purposes. HCP expects to use its revolving credit facility as a liquidity backstop for the repayment of the Notes issued under the Commercial Paper Program.
Delivering on its strategy to expand presence in the Boston region, HCP will acquire a trophy life science property -- 35 CambridgePark Drive -- for $332.5 million.
IRVINE, Calif., Sept. 9, 2019 /PRNewswire/ -- HCP, Inc. (HCP) announced today that it executed a definitive agreement to acquire, for $332.5 million, a 224,000 square foot, LEED Gold® laboratory building located at 35 CambridgePark Drive, which is expected to close in December 2019. The property is being purchased from The Davis Companies and Invesco Real Estate ("Invesco"). 35 CambridgePark Drive is located in the Cambridge submarket of Boston, Massachusetts, adjacent to HCP's recently acquired property at 87 CambridgePark Drive and future development opportunity at 101 CambridgePark Drive. Combined, HCP has created up to 440,000 square feet of contiguous space across a modern campus.
EVP, CDO and COO of Hcp Inc (30-Year Financial, Insider Trades) Thomas Klaritch (insider trades) sold 35,014 shares of HCP on 09/04/2019 at an average price of $36.02 a share. Continue reading...
The latest unveiling of Public Storage's (PSA) storage units in Murfreesboro comes as part of the company's effort to expand in this region which has been witnessing rapid growth of the neighborhood.
Boston Properties (BXP) will redeem its outstanding 5.625% senior notes due in 2020 by using proceed raised from sale of 2.9% senior notes, which will likely result in interest saving.
HCP's efforts to expand its medical office and life-science portfolio, a diversified and high-quality portfolio and favorable demographic trends make it an attractive pick.
HCP (HCP) delivered FFO and revenue surprises of 2.33% and 9.98%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?